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Objectives. Poor adherence is one of the biggest obstacles in therapeutic control of high blood pressure. The objectives of this
study were (i) to measure adherence to antihypertensive therapy in a representative sample of the hypertensive Pakistani
population and (ii) to investigate the factors associated with adherence in the studied population. Methods and Results. A
cross-sectional study was conducted on a simple random sample of 460 patients at the Aga Khan University Hospital (AKUH)
and National Institute of Cardiovascular Diseases, Karachi, from September 2005–May 2006. Adherence was assessed using the
Morisky Medication Adherence Scale (MMAS), with scores ranging from 0 (non-adherent) to 4 (adherent). In addition to MMAS,
patient self-reports about the number of pills taken over a prescribed period were used to estimate adherence as a percentage.
AKU Anxiety and Depression Scale (AKU-ADS) was incorporated to find any association between depression and adherence. At
a cut-off value of 80%, 77% of the cases were adherent. Upon univariate analyses, increasing age, better awareness and
increasing number of pills prescribed significantly improved adherence, while depression showed no association. Significant
associations, upon multivariate analyses, included number of drugs that a patient was taking (P,0.02) and whether he/she
was taking medication regularly or only for symptomatic relief (P,0.00001). Conclusions. Similar to what has been reported
worldwide, younger age, poor awareness, and symptomatic treatment adversely affected adherence to antihypertensive
medication in our population. In contrast, monotherapy reduced adherence, whereas psychosocial factors such as depression
showed no association. These findings may be used to identify the subset of population at risk of low adherence who should
be targeted for interventions to achieve better blood pressure control and hence prevent complications.
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INTRODUCTION
Hypertension is an overwhelming global challenge which ranks
third as a cause of disability-adjusted life-years [1]. According to
the Seventh Report of the Joint National Committee on
Hypertension, there are approximately 50 million hypertensive
individuals in the United States only and 1 billion worldwide [2].
Even though the burden of hypertension is currently centered in
economically developed countries (37.3%), developing countries
will feel a greater impact due to their larger population proportion.
Indeed estimates indicate that up to three-quarters of the world’s
hypertensive population will be in economically developing
countries by the year 2025 [1].
The National Health Survey of Pakistan (NHSP), conducted
from 1990 to 1994, showed that hypertension affects 18% of
adolescents above 15 years of age and 33% of adults above
45 years of age; less than 3% hypertensive patients, however, have
their BP controlled to 140/90 mm Hg or below and more than
70% of all hypertensive patients (85% in rural areas) in Pakistan
are not even aware of their disease [3].
Studies worldwide indicate that despite the availability of
effective medical therapy, over half of all hypertensives do not take
any treatment [4] and more than half of those on treatment have
blood pressures over the 140/90 mmHg threshold [5]. The World
Health Organization (WHO) describes poor adherence as the
most important cause of uncontrolled blood pressure and estimates
that 50–70% of people do not take their antihypertensive
medication as prescribed [6].
It has been well documented that uncontrolled blood pressure
increases the risk of ischemic heart disease 3-to 4-fold [7] and the
overall cardiovascular risk by 2-to 3-fold [8]. The incidence of
stroke increases approximately 3-fold in patients with borderline
hypertension and approximately 8-fold in those with definite
hypertension [9]. Moreover, a recent case control study has shown
that non adherence to therapy is associated with an increased risk
of stroke in patients with hypertension [10,11].
Adherence is defined by WHO as ‘‘the extent to which
a person’s behavior–taking medication, following a diet, and/or
executing lifestyle changes-corresponds with agreed recommenda-
tions from a health care provider’’ [12]. Adherence is dependent
on numerous factors and has been shown to vary from 0 to 100%
in different populations studied [12,13,14,15]. Factors such as age
[16,17], gender [18], low socioeconomic status and severity of
disease [17], class of drug prescribed [19], number of pills per day
[16,18], side effects of medication [16,17], patient’s inadequate
understanding of the disease and importance of the treatment
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PLoS ONE | www.plosone.org 1 March 2007 | Issue 3 | e280[16,17], co-morbid medical conditions [17], lack of social support
[20], poor patient-provider relationship [21], cost, forgetfulness
[22], and presence of psychological problems, especially depres-
sion [17,21], have all been shown to affect adherence in various
populations.
We undertook this research with the objectives of (i) measuring
adherence through the use of validated tools and (ii) investigating
the demographic, social and personal factors affecting patient
adherence to antihypertensive therapy in the Pakistani population.
METHODS
Study design and sample recruitment
This descriptive study was a questionnaire-based cross sectional
analysis. A simple random sample of 460 patients was selected
between September 2005 and May 2006 from two tertiary care
hospitals in Karachi, Pakistan, namely Aga Khan University
Hospital (AKUH) and National Institute of Cardiovascular
Diseases (NICVD).
AKUH is one of the most advanced private tertiary care centers
of Pakistan, and caters to a large number of people from all over
the country. NICVD is a government-run, tertiary care hospital
and as such, is approached by a population more indicative of the
country’s health status. Pakistan, as a developing country, is home
to a vast majority of people living at or below poverty line. Low-
cost services at this institute attract a greater number of patients.
NICVD was thus chosen for sample selection to increase the
reliability of our results and for better generalization of our data to
the Pakistani population.
The inclusion criteria were 1) patients of age 18 years and
above, 2) those who had been diagnosed with ‘essential’ hyper-
tension and 3) those who were on prescribed antihypertensive
medications since at least the previous one month. Patients with
co-existing medical conditions were also included. All people who
fulfilled the inclusion criteria were then assessed for familiarity
with Urdu, which is the national language of Pakistan and is
understood and spoken by most people throughout the country,
irrespective of ethnicity. Patients who could not converse in Urdu
were excluded, due to the lack of appropriate translators.
Ethical approval, informed consent and patient
privacy
Patients who agreed to participate were explained the nature and
the objectives of the study, and informed consent was formally
obtained. The study was approved by the Ethical Review Com-
mittees of AKUH and NICVD. The information about patient’s
identity was not included with the other data and only the
principal investigator had access to this information. No reference
to the patient’s identity was made at any stage during data analysis
or in the paper.
Data collection
The data collection tool was a questionnaire, designed-based on an
extensive literature review of similar studies [23,24]. The
questionnaire was administered by trained interviewers in the
Urdu language for ease of comprehension by the patients. The
tool was pilot-tested on 50 patients, who were not included in the
final study sample. In view of the responses generated in the pilot
study, we further modified our survey instrument to include more
common responses or to modify the questions. The final survey
questionnaire required approximately 20–30 minutes to adminis-
ter. The questionnaire extracted information regarding patient
demographics and clinical characteristics, including co-morbidities
such as diabetes, ischemic heart disease, neurological diseases and
others, characteristics of hypertension and anti-hypertensive
treatment, awareness about hypertension and anti-hypertensive
treatment, and factors that, in the patient’s views, encouraged or
discouraged the patient’s drug taking behavior.
Blood pressure was measured twice by the hospital health
physicians and trained investigators using aneroid sphygmoman-
ometers and stethoscopes. Blood pressure was measured in all
subjects after they were in the resting state for 10 minutes and in
sitting position in the right arm place at the level of the heart. An
appropriate-sized cuff (cuff bladder encircling at least 80% of the
arm) was used to ensure accuracy [2].
Patients were asked about details of their prescribed medication
regimen. The information obtained was tabulated. All information
was based on self-reporting and included number of prescribed
antihypertensive drugs, trade names of all prescribed drugs along
with the drug class, doses in milligrams (mg), frequency per day,
duration of intake in months, time of intake of the drug (morning,
afternoon, evening), and any side effects associated with the drug.
A standard drug manual was used to find out the generic class of
the drug. Prescriptions, whenever they were available at the time
of the interview, were used in getting reliable data, particularly
from illiterate patients.
Depression assessment tool
The Aga Khan University Anxiety and Depression Scale (AKU-ADS) [25]
was used to determine the severity of depressive symptoms in the study
population. AKU-ADS is an indigenous screening instrument that has
been developed in Urdu, for assessment of anxiety-depression syndromes.
The questionnaire is based on 25 items, 13 psychological and 12 somatic.
At a cut-off score of 20, the sensitivity of the scale is 66%, specificity 79%,
positive predictive value 83% and negative predictive value 60%. It covers
most of the clinical features specified by DSM-IV criteria, including somatic
complaints. Responses to the questions were recorded and scored as never
(0), sometimes (1), mostly (2), and always (3). As the scale is designed in
Urdu, the chances of differences in interpretation by both the interviewer
and the patient were minimal.
Measurement of adherence
Adherence was defined as ‘the extent to which patients followed
their medication schedules as prescribed by their health care
providers’ [17]. To measure adherence, patients’ self-reports were
used. Patients were asked non-judgmentally how often they missed
their doses [17]. They were asked the total number of tablets they
had been prescribed per week and how many pills they took and
missed in the last 3, 5 and 7 days, respectively. Previous studies
have adopted assessment over a longer duration of time,
sometimes as much as months, to obtain this data. We, however,
employed a shorter time period to elicit more accurate responses
by minimizing recall bias. Adherence rates were calculated as ‘pills
taken over a specific period of time, divided by pills prescribed for
that specific period of time’ [17].
To further increase the strength and consistency of our results,
we included an adherence assessment through the Morisky
Medication Adherence Scale (MMAS) [26], a 4-item question-
naire with a high reliability and validity [14,26], which has been
particularly useful in chronic conditions such as hypertension. It
measures both intentional and unintentional adherence based on
forgetfulness, carelessness, stopping medication when feeling
better, and stopping medication when feeling worse. The scale is
scored 1 point for each ‘no’ and 0 points for each ‘yes’. The total
score ranges from 0 (non adherent) to 4 (adherent) [27].
Factors of Adherence
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All statistical analyses were performed using SPSS 13.0 for
Windows. The questionnaire was pre-coded and all data was
entered and checked twice by two different investigators. Based on
a recent meta-analysis [15] of 129 studies that showed a mean
adherence rate of 76.6%, a sample size of 416 participants was
calculated for a power of 80% at 5% alpha and with a 6% margin
of error. Mean6one standard deviation were computed for all
continuous data. Frequencies were calculated for categorical
variables. Adherence was represented in percentage and treated
as a continuous variable. As described in previous studies, for
analysis of adherence a cut-off value of 80% was used for labeling
patients as adherent or non-adherent [4,16,28,29]. In univariate
analyses, means were compared using student’s t-test and
ANOVA. Categorical variables were compared using Chi-squared
and Fisher’s exact tests, as applicable. Odds ratios (with 95%
confidence intervals, CI) were calculated from the 262 tables.
Univariate and multivariate logistic regression were done using
adherent vs. non-adherent status as the outcome variable, while
various study variables were used as independent variables.
Associations of study variables with the MMAS score were
checked with the help of linear regression using MMAS score as
the dependant variable and study variables as independent
variables. A p-value of less than 0.05 was considered to be
statistically significant for all analyses.
RESULTS
After pilot-testing and refining the questionnaire with 50
individuals, we interviewed 460 patients at both study centers.
After exclusion of cases in which adherence could not be
calculated, we included data on 438 cases. In this sample, 71%
of the cases were recruited and interviewed at the NICVD, while
29% were recruited from AKUH. There were no statistically
significant differences in the adherence and the study variables
between the cases recruited from the two hospitals hence
combined analysis of the data was done (data not shown). Due
to significant difference in prevalence of hypertension in the
various ethnic groups in Pakistan, we also recorded the ethnicity as
provided by the patient. Ethnicity, however, was not associated
with adherence or other study variables and therefore was not
analyzed as a risk factor. According to the 80% cutoff level, 77%
of the cases were adherent (n=336, adherence$80%, mean
adherence=9865%) and 23% were non-adherent (n=102,
adherence#80%, mean adherence=39629%).
Demographic and clinical characteristics
There were 199 males (mean age 54610 years) and 239 females
(mean age 50611 years); 20% of the total cases were younger than
40 and 19% older than 60 years. Although we found adherence to
increase with increasing age (P,0.02), age remained only
marginally different after division of cases into adherent and
non-adherent groups. Subjects who were less than 40 years old
were less adherent than those older than 70. The highest mean
adherence rate was observed in the age group 70–80 years (mean
adherence=91614%). Although mean adherence showed an
overall increase with increasing monthly income and increasing
level of education, no significant difference was observed. Table 1
shows the distribution of study variables among the adherent and
non-adherent groups. Most of the cases (89%) were married. The
mean AKU-ADS score was 19611 and 190 (43%) cases were
depressed according to their AKU-ADS score. A significant
proportion of the depressed patients were females 113 (73%,
P,0.001). Although the presence of a single co-morbid condition
slightly increased the adherence, the presence of two or more co-
morbids led to a gradual decrease in adherence (P.0.05). The
most frequently reported co-morbids were diabetes (23.1%) and
ischemic heart disease (25.8%). Associations between co-morbid-
ities and adherence, however, were not statistically significant.
Characteristics of hypertension and anti-
hypertensive treatment
Table 2 shows the prevalence of various characteristics of
hypertension and anti-hypertensive treatment in the adherent
and non-adherent groups. Most patients (70.8%) discovered their
disease during medical checkup for symptoms related to
hypertension and/or its complications.
A greater proportion of the cases suffering from hypertension-
related complications were adherent (P.0.05). A large proportion
of our study sample had never been hospitalized (45%). The
patients who had been hospitalized in the previous two years had
significantly higher adherence (P,0.05). Surprisingly adherence
increased with increasing number of anti-hypertensive drugs that
a person was taking (P,0.05).
Awareness about hypertension and anti-
hypertensive treatment
The overall level of awareness about hypertension and its
treatment was very low. As shown in Table 3, 24% of the study
sample took their medication only when they thought they had
symptoms of high blood pressure. This patient group had very low
adherence. The patients who considered every dose to affect blood
pressure had significantly higher adherence (P,0.001) and lower
systolic and diastolic blood pressures. A very small proportion of
patients were aware of the risk factors for hypertension and an
even smaller proportion knew about the complications. Greater
awareness was associated with higher adherence.
Factors associated with low MMAS
The mean MMAS score in the overall sample was 2.561.3.
MMAS score was significantly higher (P,0.001) in the adherent
group (2.761.2) compared to the non-adherent group (1.761).
Table 4 lists the patient variables significantly associated with the
MMAS. MMAS scores of #2 were associated with a mean
adherence ,73%. The patients with MMAS scores #2 were
relatively younger (51 vs. 53 years), were illiterate or at a lower
level of education (P,0.05), belonged to a lower income subgroup
(P,0.05), and had higher systolic (140626 vs. 136619 mmHg,
P,0.05) and diastolic (86618 vs. 82613, P,0.01) pressures. A
significantly greater proportion of patients with MMAS score #2
were depressed (50% vs. 38%, P,0.05), according to AKU-ADS.
Table 5 shows the prevalence of various personal, social and
behavioral characteristics that in the patient’s views affected their
drug adherence. The prevalence of most of the factors was
significantly different in the adherent and non-adherent groups.
While the common encouraging factors, such as understanding the
need and effectiveness of the prescribed medication and
availability of support system, were significantly associated with
better adherence, the most common discouraging factors cited in
literature such as forgetfulness [22], side effects [16,17], cost of
medication [16] and lack of access to medication [14] did not show
statistically significant associations with non-adherence.
Upon multivariate analysis, the only factors associated with
adherence were the number of drugs that a patient was taking
(P,0.02) and whether he/she was taking medication regularly or
only for symptomatic relief (P,0.00001)
Factors of Adherence
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Adherence to antihypertensive therapy as measured by our study
was 77% in the studied Pakistani population, when defined by the
$80% cut off. The factors showing significant associations with
adherence were age, number of drugs prescribed and patients’
knowledge of the disease and treatment, including their beliefs and
practices.
Our study reports a higher adherence in the Pakistani
population than what has been reported previously in a local
study (57%) [22]. This could be due to measurement of adherence
based on different criteria in the two studies, along with variation
in the subset of population which served as the study sample.
Among the studies conducted on various populations of the
world, using a similar cut-off, the adherence we observe is higher
than what has been reported in a similar study in Malaysia (44.2%)
[16], comparable to a study in Egypt (74.1%) [23] and lower than
what a study in the Western population (Scotland) reports (91%)
[4]. Hence, we found that people of a developing country, like
Pakistan, are generally more adherent to their medication than
what might be assumed. However, population studies with larger
samples are needed to support our claim.
Age was found to be significantly and independently associated
with adherence in our study, with better adherence observed in
older people. This finding is consistent with a number of other
studies [30,31,32] including the regional study in Malaysia [16],
although there are studies which show either no association [4,23]
or decreasing adherence with increasing age [33]. Increasing self-
reliance in old age has been shown to decrease adherence [34]. In
the Pakistani population, a better social support structure ensured
by the common extended family system, reduces self-reliance and
could be the reason for better adherence in this age group. It is
usual for other family members to take full responsibility of the
medication routine of the families’ patients.
An inverse relationship was observed between adherence and
number of pills prescribed. Patients on monotherapy had a mean
Table 1. Demographic and clinical characteristics of the study population
..................................................................................................................................................
Mean6SD/n (%) Mean Adherence Adherent .80% Non-Adherent ,80% Unadjusted
n=438 n=336 n=102 OR (95% CI)
Age (years) 52611 84629 52611 49611 1.0 (1.00–1.04)
{
Gender: n (%)
Male 199 (45.4) 83%631 154 (77.4) 45 (22.6) NS
Female 239 (54.6) 85%626 182 (76.2) 57 (23.8)
Education status: n (%)
Illiterate 120 (27) 81%633 86 (72) 34 (28) NS
Primary or below 111 (25) 86%627 90 (81) 21 (19)
Intermediate and secondary 124 (28) 84%628 95 (77) 29 (23)
Graduate and above 83 (19) 86%627 65 (78) 18 (22)
Monthly Income: (PKR) n (%)
Lower (,5000) 173 (39.5) 82%632 131 (76) 42 (24) NS
Lower Middle (5k–10k) 120 (27.4) 86%625 93 (78) 27 (23)
Middle (10k–20k) 62 (14.2) 80%632 44 (71) 18 (29)
Upper Middle (20k–50k) 57 (13) 87%623 46 (81) 11 (19)
Upper (.50k) 26 (5.9) 89%626 22 (85) 4 (15
Marital Status: n (%)
Single 14 (3.2) 66%637 7 (50) 7 (50) NS
Married 379 (86.5) 84%629 295 (78) 84 (22)
Divorced/Widowed 45 (10.3) 86%623 34 (76) 11 (24)
Depression (AKU-ADS): n (%)
Depressed 190 (43.4) 83%630 142 (75) 48 (25) NS
Non-depressed 248 (56.6) 85%628 194 (78) 54 (22)
No. of Comorbids: n (%)
none 198 (45.2) 83%629 150 (75.8) 48 (24.2) NS
1 188 (42.9) 85%628 147 (78.2) 41 (21.8)
2 47 (10.7) 84%627 36 (76.6) 11 (23.4)
3 or more 5 (1.1) 69%642 3 (60) 2 (40)
Family Hx. of HTN: n (%)
Present 212 (48.4) 86%627 169 (80) 43 (20) NS
Absent 226 (51.6) 82%631 167 (74) 59 (26)
{-P,0.05
HTN–Hypertension, PKR–Pakistani Rupee, AKU–Aga Khan University Hospital, NICVD–National Institute of Cardiovascular Diseases, AKU-ADS-Aga Khan University-
Anxiety and Depression Scale, Hx. –History
doi:10.1371/journal.pone.0000280.t001
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PLoS ONE | www.plosone.org 4 March 2007 | Issue 3 | e280adherence of 79% compared to 90% for those on three drugs or
more (OR; 95% CI, 0.3; 0.1–0.6). This is in contrast to what has
been frequently reported so far. A recent meta-analysis of eight
studies reports that the average adherence for once-daily dosing
was significantly higher than for multiple daily dosing (91.4% vs.
83.2%, respectively, P,0.001) [35]. Some latest studies, however,
have identified no relation between increasing number of drugs
and poor adherence [4], including one such study in an Asian
population [16]. One reason for our finding could be that patients
on multiple pills feel that the severity of their disease is significant
and hence become more cautious with their treatment, compared
to those on monotherapy, who may take treatment lightly.
Another reason may perhaps be that when patients have to take
multiple medications, they are less likely to forget to take them,
compared to having to take only one pill.
Baune et al, showed a significant correlation between education
and QOL among patients with hypertension in Gaza Strip and
hypothesized that educational interventions would be essential in
preventing high blood pressures and consequent mortality [36].
Knowledge of hypertension significantly affected adherence in our
study sample. Patients who were aware of the association between
certain risk factors for hypertension, such as high salt intake, stress
and a positive family history, had better adherence compared to
those who with poorer knowledge. Studies from the developed
world, however, indicate no association between patients’
knowledge and adherence [32,37].
Patients’ beliefs and attitudes have been explored in studies
worldwide to explain not taking medication as prescribed [17].
Egan et al. found forgetfulness, adverse effects and not liking to
take medication among the reasons for poor adherence in
a nationally representative sample in the United States [38].
Commonly encouraging factors, such as understanding the need
and effectiveness of medication, a good support system and
employing methods to reduce forgetfulness such as keeping
medication in sight, were all significantly associated with better
adherence in our population. Similarly, among the discouraging
factors cited in literature, most commonly reported in our
population were forgetfulness (48%) as has been reported by an
earlier local study [22], followed by cost (40%) and fear of getting
used to medication (27%). These were, however, factors that
reduced adherence among the adherent (.80% adherence)
population. This was different from the major factors reducing
adherence in the non-adherent (,80% adherence) patients, whose
main issues were lack of understanding of need of medication
(70%) and lack of understanding of effectiveness of medication
(59%).
Depression has recently been added to the list of factors associ-
ated with non-adherence to anti-hypertensive medication [32].
Wang et al. [21] demonstrated a significant association between
depression, as a multivariate factor, and non-adherence. In our
study, however, depression was not found to independently correl-
ate with non-adherence.
Our study design was limited in several aspects. Self-reporting
was used as the only method of measuring adherence. Although
this method has the disadvantages of recall bias, of eliciting only
socially acceptable responses and hence, may overestimate
Table 2. Characteristics of hypertension and anti-hypertensive treatment
..................................................................................................................................................
Mean6SD/n (%) Mean Adherence Adherent .80% Non-Adherent ,80% Unadjusted
n=438 n=336 n=102 OR (95% CI)
Spot BP: (mmHg)
Systolic BP 138623 - 137622 139627 NS
Diastolic BP 84615 83615 86617
Method of initial diagnosis:
Regular checkup 71 (16.2) 87%628 58 (82) 13 (18) NS
Checkup for HTN related symptoms 310 (70.8) 84%628 235 (76) 75 (24)
Checkup of other causes 57 (13.0) 82%632 43 (75) 14 (25)
HTN related complications:
Present 248 (57) 84%629 193 (78) 55 (22) NS
Absent 190 (43) 84%628 143 (75) 47 (25
Time since last hospital visit: (months)
,24 months 135 (56.5) 88%625 112 (83) 23 (17) -
.24 months 104 (43.5) 80%631 73 (70) 31 (30) 2 (1.1–3.8)
{
No. of Antihypertensive drugs:
Monotherapy 201 (46) 79%631 138 (69) 63 (31) 0.3 (0.1–0.6)
{
Two drugs 163 (37) 87%627 133 (82) 30 (18) 0.6 (0.3–1.4)
Three drugs or more 74 (17) 90%624 65 (87) 9 (12) -
Who pays for medication:
Self 166 (38) 82%631 124 (75) 42 (25) NS
Family 162 (37) 85%627 127 (78) 35 (22)
Welfare/Charity 80 (18) 81%630 59 (74) 21 (26)
Employer 29 (6.6) 93%617 25 (86) 4 (14)
{-P,0.05
HTN–Hypertension, BP–Blood pressure.
doi:10.1371/journal.pone.0000280.t002
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PLoS ONE | www.plosone.org 5 March 2007 | Issue 3 | e280Table 3. Awareness about hypertension and anti-hypertensive treatment
..................................................................................................................................................
Mean6SD/n (%) Mean Adherence Adherent Non-Adherent Unadjusted
n=438 Adherence .80% Adherence ,80% OR (95% CI)
n=336 n=102
When do you take your medication:
Regularly 332 (76) 93%616 291 (88) 41 (12) -
For symptomatic relief 106 (24) 57%640 45 (43) 61 (58) 9.6 (5.8–15.9){
In your view your blood pressure is:
Controlled 313 (72) 86%626 245 (78) 68 (22) NS
Uncontrolled 124 (28) 79%633 91 (73) 33 (27)
Missing a single dose:
Does not affect BP 192 (44) 77%633 131 (68) 61 (32) 2.3 (1.5–3.7){
Affects BP 246 (56) 90%623 205 (83) 41 (17) -
Following increases risk for HTN:
Smoking 51 (12) 39 (77) 12 (24) NS
Alcohol 9 (2) 9 (100) 249 NS
High salt 165 (38) 116 (70) (30) 0.6 (0.4–0.9){
Diabetes Mellitus 26 (5.9) 24 (92) 2 (8) NS
Obesity 44 (10) - 37 (84) 7 (16) NS
Male gender 18 (4.1) 15 (83) 3 (17) NS
Stress 276 (63) 202 (73) 74 (27) 0.6 (0.4–0.9){
Age 31 (7) 27 (87) 4 (13) NS
Family History 61 (14) 54 (89) 7 (12) 2.6 (1.1–5.9){
Physical inactivity 32 (7.3) 27 (84) 5 (16) NS
Following organs are affected by HTN:
Heart 297 (68) 226 (76) 71 (24) NS
CNS 148 (34) - 114 (77) 34 (23) NS
Eyes 45 (10) 36 (80) 9 (20) NS
Kidney 95 (22) 81 (85) 14 (15) 2 (1.0–3.7){
Vasculature 34 (8) 24 (71) 10 (29) NS
Extra Salt added to diet 33 (7.5) 83%631 25 (76) 8 (24) NS
{-P,0.05
HTN–Hypertension, BP–Blood pressure.
doi:10.1371/journal.pone.0000280.t003
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Table 4. Patient factors associated with MMAS
..................................................................................................................................................
b (95% CI) p value
Adherence 0.016 (0.012–0.02) ,0.001
Age 0.01 (0.002–0.03) 0.02
Education status 0.12 (0.01–0.2) 0.03
Monthly Income 0.16 (0.06–0.26) 0.001
No. of prescribed drugs 0.17 (0.08–0.33) 0.04
Patient’s assessment of his/her blood pressure 20.36 (20.63– 20.1) 0.007
Does missing a dose make any difference? 20.58 (20.82– 20.34) ,0.001
Do you take you medication regularly or only for symptomatic relief? 21.2 (21.5– 20.98) ,0.001
Presence of depression 0.34 (0.1–0.6) 0.005
{-P,0.05
doi:10.1371/journal.pone.0000280.t004
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PLoS ONE | www.plosone.org 6 March 2007 | Issue 3 | e280adherence [14], it is simple, economically feasible and the most
useful method in clinical settings [17]. Response rate of the
participants was not recorded and thus in this study it is assumed
that responders and non-responders are similar in distribution of
the recorded variables. Apart from harboring the known limita-
tions of the cross-sectional design, our study involved patients
recruited from tertiary care hospitals only, and hence the results
cannot be generalized. As we included patients with co-existing
illnesses, some of our results may not be purely indicative of the
characteristics of hypertensive patients. We did not include
patients who could not converse in Urdu and this further restricts
the generalization of our findings. Most adherence studies based
on self-reporting ask patients to give information about long
durations (usually ranging from 1 month to 1 year) to avoid any
bias introduced by the brevity of the duration. Increasing the
duration of time period could give a more generalized view of the
patient’s adherence over a longer period of time but at the same
time increases the chance of introducing recall bias. Self-reported
adherence based on a short duration of time has equal chances of
being under-reported as over-reported, depending on the patient’s
behavior in the recent past, but minimizes the chance of recall bias
and hence is more accurate. The published literature suggests that
people are more accurate in reporting non-adherence when asked
simple questions about recent behavior [27,39].
The adherence goal of 80% of prescribed dose is used
conventionally in clinical trials of safety and efficacy [4]. Hence,
we used this value as a cut point for labeling patients as adherent
and non-adherent. All the analyses, however, were repeated using
a higher cut-off of 90% in order to dichotomize adherence and the
results reported here were found to be consistent.
The use of validated tools in our study further strengthens the
reliability of our results. MMAS had a significant linear relation
with adherence measured as a continuum. Most of the factors
associated with non-adherence discussed above were associated
with low MMAS scores of #2, including those which did not show
an association with adherence at the cut-off of 80%, such as
depression. More studies, however, are needed to demonstrate the
validity of MMAS in the Pakistani population. Hence, we have
reported only those factors as significantly affecting adherence that
were common to both our criteria for measurement of adherence.
In conclusion, we found younger age, monotherapy, poor
awareness and symptomatic treatment to be the strongest factors
affecting adherence to anti-hypertensive medication amongst
Pakistani patients. Future studies are recommended to confirm
our findings, as adherence to medication predicts better outcomes
and indicators of poor adherence to a medication regimen are
a useful resource for physicians to help identify patients who are
most in need of interventions to improve adherence.
We recommend the implementation of education campaigns to
increase awareness about the risk factors, natural history,
complications and treatment of hypertension. Global events, such
as World Hypertension Day, could be used as a forum to highlight
these issues. Patient support groups can be employed to help the
non-adherent. Patients who have suffered complications due to
non-adherence could be requested to voluntarily share their
experiences. Print and audiovisual media would be very helpful in
dissemination of information. Most importantly, though, physi-
cians have to pay special attention to patient education and
counseling when treating hypertensive patients.
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